Cite
HARVARD Citation
Rodriguez Otero, P. et al. (n.d.). S188: TECLISTAMAB IN COMBINATION WITH DARATUMUMAB, A NOVEL, IMMUNOTHERAPY-BASED APPROACH FOR THE TREATMENT OF RELAPSED/REFRACTORY MULTIPLE MYELOMA: UPDATED PHASE 1B RESULTS. HemaSphere. pp. 89-90. [Online].